Tech Company Financing Transactions

Rebound Therapeutics Funding Round

Rebound Therapeutics, based in Irvine, raised $16.5 million from HBM Healthcare Investments, Invus and Wexford Capital.

Transaction Overview

Announced On
7/26/2017
Transaction Type
Venture Equity
Amount
$16,500,000
Round
Series B
Proceeds Purpose
The funding will support ongoing product development, worldwide regulatory approvals, manufacturing scale-up and commercialization efforts.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13844 Alton Pkwy. 131
Irvine, CA 92618
USA
Website
Email Address
Not Recorded
Overview
Rebound Therapeutics Corp. operates in the technology industry. The company was incorporated in 2015 and is based in Irvine, California.
Profile
Rebound Therapeutics LinkedIn Company Profile
Social Media
Rebound Therapeutics Company Twitter Account
Company News
Rebound Therapeutics News
Facebook
Rebound Therapeutics on Facebook
YouTube
Rebound Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Valko
  Jeffrey Valko LinkedIn Profile  Jeffrey Valko Twitter Account  Jeffrey Valko News  Jeffrey Valko on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/26/2017: Grabr venture capital transaction
Next: 7/26/2017: Bricata venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary